|
|
Volumn 23, Issue 2, 2003, Pages 98-101
|
|
Investigation of accolate and singulair for treatment of capsular contracture yields safety concerns
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTIBIOTIC AGENT;
GLUCOCORTICOID;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
PACLITAXEL;
PENTOXIFYLLINE;
PLACEBO;
RAPAMYCIN;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ZAFIRLUKAST;
ARTICLE;
ASTHMA;
BREAST AUGMENTATION;
CHURG STRAUSS SYNDROME;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DELIVERY SYSTEM;
DRUG FATALITY;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
HAIR LOSS;
HEADACHE;
HEALTH CARE POLICY;
HEPATITIS;
HUMAN;
INCIDENCE;
INFORMATION PROCESSING;
LIVER DYSFUNCTION;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MEDICAL SOCIETY;
MUSCLE CONTRACTURE;
NAUSEA;
POSTMARKETING SURVEILLANCE;
TREATMENT INDICATION;
VASCULITIS;
|
|
EID: 0038543505
PISSN: 1090820X
EISSN: None
Source Type: Journal
DOI: 10.1067/maj.2003.19 Document Type: Article |
|
Times cited : (37)
|
|
References (6)
|
